Glaucoma laser stability and sustainability study
Part of Eyes & vision clinical trials.
This study tests whether a laser treatment helps keep eye pressure stable in people with early glaucoma or high eye pressure who have not used any eye drops or medications before. It may be a good option if you are looking for a treatment that doesn't require daily eye drops.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older
- You have high eye pressure or early glaucoma in both eyes
- You have never been treated with any eye drops or oral medications for glaucoma
- Your eye pressure is between 21 and 35 mmHg without medication, and both eyes are within 3 mmHg of each other
- Your vision is 20/50 or better (with glasses or contacts if needed)
- You are willing to come for follow-up visits over 12 months after treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new laser treatment called DSLT for people who have just been diagnosed with open-angle glaucoma or a similar condition like ocular hypertension. It aims to see if the laser can lower eye pressure by at least 20% after six months without needing any eye drops.
This trial tests a new laser treatment called DSLT for people with normal-tension glaucoma, a type of glaucoma where eye pressure is normal but vision is still damaged. It aims to lower eye pressure and help preserve vision. The study is specifically for people of Asian descent.
This trial tests a laser treatment called DSLT to see how it affects eye pressure changes over 6 months. It may help people with open-angle glaucoma or high eye pressure who are currently using 0 to 3 types of pressure-lowering eye drops.
This trial tests how well a laser treatment called selective laser trabeculoplasty works in people with open-angle glaucoma. It looks at results over 12 months to see if it helps lower eye pressure.
This trial tests a special laser treatment called Direct Selective Laser Trabeculoplasty (DSLT) for people with pseudoexfoliation glaucoma, a type of glaucoma that can be harder to treat. The treatment aims to lower eye pressure and may help delay or avoid the need for daily eye drops.
This study tests a newer type of laser treatment for glaucoma, called direct selective laser trabeculoplasty (DSLT), in people who have already had a standard SLT laser before. It aims to see if DSLT can further lower eye pressure, which may help protect your vision.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.